Group 1 - The net asset value (NAV) of EfTEN United Property Fund units was 11.53 euros at the end of April, reflecting a monthly increase of 1.6% [1] - The fund reported a net profit of 449 thousand euros in April and a total net profit of 1.15 million euros for the first four months of 2025, compared to 331 thousand euros during the same period last year [1] - If the investment in EfTEN Real Estate Fund AS shares were recorded at its NAV, the NAV would be 11.58 euros, indicating a 1.4% monthly increase [1] Group 2 - The fund's largest profit in April came from its investment in Invego Uus-Järveküla OÜ, amounting to 274 thousand euros, with the company earning a total profit of 342 thousand euros from the transfer of terraced houses [2] - The next stage of the development, consisting of 17 terraced houses, is expected to be completed in June 2025, with 14 of the houses already booked by clients [2] Group 3 - The cash balance of EfTEN United Property Fund increased by 1.582 million euros in April, which included loan payments and interest from Invego Uus-Järveküla OÜ totaling 1.5 million euros and dividend receipts of 277 thousand euros [3] - The fund will distribute its largest income in history on May 29, amounting to 1.416 million euros, or 57 euro cents per fund unit [3]

Core Viewpoint - The collaboration between Biotalys and AgroFresh aims to develop sustainable biological fungicides to reduce food waste and enhance the freshness of produce, addressing the significant issue of post-harvest losses, which are estimated at 14% globally [1][2]. Group 1: Company Overview - Biotalys is an AgTech company focused on developing protein-based biocontrol solutions for sustainable crop protection, utilizing its AGROBODY™ technology platform [6][7]. - AgroFresh is a leader in post-harvest quality and freshness solutions, with over 40 years of experience in enhancing the shelf-life of fresh produce and reducing food loss [5]. Group 2: Market Context - The global post-harvest fungicide market is valued at $300 million, indicating a significant opportunity for Biotalys to expand its presence in this critical segment [3][4]. - Fungal decay poses a major challenge in the post-harvest supply chain, making effective disease management essential as fresh produce becomes more susceptible to spoilage after harvest [2]. Group 3: Collaboration Goals - The partnership between Biotalys and AgroFresh aims to innovate and provide environmentally friendly biological solutions that meet the evolving needs of global markets, ultimately helping to reduce food waste [3][2]. - The collaboration is expected to enhance the innovation pipeline of AgroFresh, introducing novel technologies that preserve freshness and support produce suppliers [2].

Company Overview - SalMar ASA is one of the world's largest and most efficient producers of salmon, with farming operations in Central Norway, Northern Norway, Offshore, and Iceland, as well as significant harvesting and secondary processing operations [9] - The company owns 50% of Scottish Sea Farms Ltd, further enhancing its market presence [9] Recent Developments - SalMar has completed the purchase of a controlling stake in AS Knutshaugfisk, which has 3,466 tons MTB in licenses and four farming locations in Central Norway [2] - A merger plan between Wilsgård AS and SalMar Farming AS has been approved, with SalMar holding a 37.5% stake in Wilsgård. This merger is expected to enhance operational efficiency and financial robustness [3][4] Financial Performance - In Q1 2025, SalMar reported an operational EBIT of NOK 798 million with a harvest volume of 42,700 tonnes, resulting in an operational EBIT per kg of NOK 18.7 [7] - The harvest volume for Norway was 40,400 tonnes, with an operational EBIT of NOK 852 million, translating to NOK 21.1 per kg [7] - The first quarter was characterized by low harvest volumes, primarily due to late harvesting and fish welfare considerations, leading to a high share of downgraded fish and negatively impacting price achievement [7] Future Outlook - For 2025, SalMar expects a total harvest volume of 294,000 tonnes, representing a 17% growth compared to 2024, with specific contributions from Norway, SalMar Ocean, Iceland, and Scottish Sea Farms [5] - The company anticipates strong demand for its products despite global market uncertainties and expects lower global supply growth in the latter half of 2025 [6]

Core Insights - GlobalFoundries (GF) has signed a Memorandum of Understanding (MOU) with the Agency for Science, Technology and Research (A*STAR) to enhance its advanced packaging capabilities in Singapore [1][3] - The collaboration aims to address the growing demand for advanced packaging in the semiconductor industry, driven by applications in artificial intelligence (AI) and data-intensive technologies [2][4] - A*STAR will provide GF with access to R&D facilities and technical support, while GF will supply critical equipment to A*STAR, facilitating mutual growth in advanced packaging technologies [3][5] Company Developments - The partnership will enable skills enhancement initiatives for GF employees, focusing on developing expertise in advanced packaging [4][6] - This collaboration aligns with GF's global advanced packaging roadmap and its commitment to producing energy-efficient chips essential for AI applications [4][6] - GF's strategic roadmap includes the establishment of an Advanced Packaging and Photonics Center in New York, complementing the efforts in Singapore [6] Industry Context - Advanced packaging is a key R&D priority for the semiconductor industry, essential for delivering compact, high-performance, and energy-efficient solutions [2] - Singapore is positioning itself as a critical node in the global semiconductor supply chain, emphasizing the importance of R&D collaboration between public research and industry [5][6] - The partnership reflects a broader trend of nurturing high technology talent and continuous upskilling in response to evolving industry needs [4][5]

Core Viewpoint - Ryman Hospitality Properties, Inc. has announced an upsized public offering of common stock to fund a portion of the acquisition of JW Marriott Phoenix Desert Ridge Resort & Spa, with the offering size increased from 2.3 million shares to 2.6 million shares at a price of $96.20 per share [1][2]. Group 1: Offering Details - The offering will consist of 2,600,000 shares of common stock, with an additional 30-day option for underwriters to purchase up to 390,000 more shares [1]. - The expected closing date for the offering is around May 21, 2025, subject to customary closing conditions [1]. - The offering is being conducted under the Company's shelf registration statement on Form S-3, which became effective on June 5, 2023 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be contributed to RHP Hotel Properties, LP, and will primarily fund a portion of the approximately $865 million purchase price for the Desert Ridge Acquisition [2]. - Any remaining funds from the offering will be allocated for general corporate purposes if the Desert Ridge Acquisition does not close [2]. Group 3: Underwriters - Morgan Stanley, BofA Securities, J.P. Morgan, and Wells Fargo Securities are acting as active joint book-running managers for the offering [3]. - Other bookrunners include Deutsche Bank Securities, BTIG, Credit Agricole CIB, Scotiabank, SMBC Nikko, and Raymond James [3]. Group 4: Company Overview - Ryman Hospitality Properties, Inc. is a leading lodging and hospitality real estate investment trust specializing in upscale convention center resorts and entertainment experiences [6]. - The Company owns several major properties, including Gaylord Opryland Resort & Convention Center and JW Marriott San Antonio Hill Country Resort & Spa, totaling 11,414 rooms and over 3 million square feet of meeting space [6][7].

Core Viewpoint - Mainz Biomed N.V. has announced a follow-on offering of 2,000,000 units at an effective price of $2.00 per unit, aiming for gross proceeds of approximately $4.0 million [1] Group 1: Offering Details - Each unit in the offering consists of one ordinary share (or pre-funded warrant), one Series A warrant, and one Series B warrant [1] - The Series A and Series B warrants are immediately exercisable at an exercise price of $2.00 per share, with Series A expiring in five years and Series B expiring either 30 days after results from the eAArly Detect 2 study or one year from issuance [1] - The offering is expected to close on or about May 21, 2025, subject to customary closing conditions [2] Group 2: Warrant Amendment Agreement - The company has entered into a Warrant Amendment Agreement to reduce the effective strike price of previously issued Series A and Series B Warrants from December 12, 2024, to an amended exercise price of $2.00 [3] Group 3: Regulatory Information - The newly issued securities are being offered under a registration statement on Form F-1, which was declared effective by the SEC on May 16, 2025 [4] - A final prospectus related to the offering will be filed with the SEC, and copies can be obtained from Maxim Group LLC [4] Group 4: Company Overview - Mainz Biomed specializes in molecular genetic diagnostic solutions for early cancer detection, with its flagship product being ColoAlert®, a non-invasive test for colorectal cancer marketed in Europe [5] - The company is conducting a clinical study to prepare for its pivotal FDA clinical study and US regulatory approval [5] - Mainz Biomed's product portfolio also includes PancAlert, an early-stage pancreatic cancer screening test [5]

Core Insights - PrimeEnergy Resources Corporation reported a 16.4% year-over-year increase in revenue for Q1 2025, driven by growth in oil and gas production [1][6] - Despite a decline in earnings per share compared to Q1 2024, the company emphasized significant shareholder returns and operational momentum [1][4] Financial Performance - Revenue reached $50.1 million, up 16.4% from the previous year [6] - Oil production increased to 457,000 barrels, a rise of 6.0% [6] - Natural gas production surged to 2.39 billion cubic feet (Bcf), marking a 106.6% increase [6] - NGL (Natural Gas Liquids) production rose to 454,000 barrels, up 120.4% [6] - Net income was reported at $9.1 million, a decrease of 19.3% [6] - Diluted earnings per share (EPS) fell to $3.72, down 15.7% [6] Shareholder Returns - The company has returned a total of $112.6 million to shareholders through stock repurchases since initiating its buyback program [3] - In 2025, 47,970 shares were repurchased at a cost of $9.17 million [6] - As of May 19, 2025, the outstanding share count was 2,428,000, including vested options [3] Operational Highlights - The CFO highlighted strong operational momentum with significant growth in natural gas and NGL volumes [4] - Total assets increased to $339.3 million at the end of the quarter, up from $324.6 million as of December 31, 2024 [3]

Core Insights - AEM Holdings Ltd. collaborates with Intel Foundry to enhance access to System-Level Test (SLT) and Burn-In capabilities for advanced computing devices, aiming to accelerate time-to-market for fabless customers [1][2][5] Group 1: Collaboration Details - The partnership leverages decades of collaboration to create a mature SLT and Burn-In ecosystem, essential for high-performance computing (HPC) and artificial intelligence (AI) applications [1][2] - AEM provides device-specific configurable test units, advanced handlers, and software support, complementing Intel Foundry's services such as factory automation and test program development [3][9] Group 2: Customer Benefits - Key benefits for customers include enhanced test coverage, reduced capital expenditure, and faster time-to-market, supported by a scalable platform and local engineering teams [5][6][9] - The collaboration aims to meet rising performance demands and facilitate chiplet-based architectures, ensuring reliability for AI and HPC applications [5][6] Group 3: Company Overview - AEM Holdings Ltd. is a global leader in test innovation with a presence across Asia, Europe, and the United States, offering comprehensive semiconductor and electronics test solutions [7][8]

Core Viewpoint - Qifu Technology reported strong financial results for Q1 2025, demonstrating resilience amid macroeconomic challenges, with significant growth in user activity and loan facilitation volume [4][5][35]. Business Highlights - As of March 31, 2025, Qifu Technology connected 163 financial institutional partners and 268.2 million consumers, marking an 11.1% increase from 241.4 million a year ago [4]. - The number of cumulative users with approved credit lines reached 58.4 million, up 11.6% from 52.3 million a year ago [4]. - Cumulative borrowers with successful drawdown totaled 35.5 million, reflecting a 13.8% increase from 31.2 million a year ago [4]. - Financial institutional partners originated 24,401,374 loans through the platform in Q1 2025 [4]. Financial Highlights - Total net revenue for Q1 2025 was RMB 4,690.7 million (US$ 646.4 million), compared to RMB 4,153.2 million in the same period of 2024 [5][9]. - Net income was RMB 1,796.6 million (US$ 247.6 million), an increase from RMB 1,160.1 million in Q1 2024 [28]. - Non-GAAP net income for the quarter was RMB 1,926.2 million (US$ 265.4 million), compared to RMB 1,204.8 million in the same period of 2024 [28]. - The weighted average contractual tenor of loans originated was approximately 10.17 months, slightly up from 10.10 months in Q1 2024 [4]. Revenue Breakdown - Revenue from Credit Driven Services was RMB 3,110.9 million (US$ 428.7 million), up from RMB 3,016.3 million in Q1 2024 [9]. - Loan facilitation and servicing fees under the capital-heavy model were RMB 429.8 million (US$ 59.2 million), significantly higher than RMB 243.8 million in the same period of 2024 [10]. - Financing income increased to RMB 1,817.2 million (US$ 250.4 million) from RMB 1,535.0 million in Q1 2024 [11]. - Revenue from releasing of guarantee liabilities decreased to RMB 778.2 million (US$ 107.2 million) from RMB 1,166.0 million in the same period of 2024 [12]. Operating Costs and Expenses - Total operating costs and expenses were RMB 2,716.0 million (US$ 374.3 million), down from RMB 2,789.1 million in Q1 2024 [17]. - Sales and marketing expenses rose to RMB 591.5 million (US$ 81.5 million) from RMB 415.6 million in the same period of 2024, reflecting increased marketing efforts [19]. - General and administrative expenses increased to RMB 196.5 million (US$ 27.1 million) from RMB 106.4 million in Q1 2024, primarily due to higher share-based compensations [20]. Share Repurchase and Financial Position - The company completed a US$ 690 million convertible notes offering, providing resources to accelerate share repurchase programs [8]. - As of May 19, 2025, approximately 4.4 million ADSs were repurchased for about US$ 178 million under the 2025 Share Repurchase Plan [33]. - The company expects to use remaining net proceeds from the convertible notes offering for further share repurchases [34]. Business Outlook - For Q2 2025, the company anticipates net income between RMB 1.65 billion and RMB 1.75 billion, representing a year-on-year growth of 24% to 31% [35].

Core Insights - Micron Technology, Inc. has launched two new high-performance SSDs, the Crucial T710 PCIe Gen5 NVMe SSD and the Crucial X10 Portable SSD, at Computex 2025, enhancing its leadership in consumer storage [1][2] Product Features - The Crucial T710 SSD offers unprecedented Gen5 performance, particularly beneficial for gaming and creative applications, with up to 67% more IOPs per watt compared to previous Gen5 drives, and capacity options up to 4TB [7][8] - The Crucial X10 Portable SSD features read speeds of up to 2,100 MB/s, which is double the speed of its predecessor, and is available in storage capacities of 4TB, 6TB, and 8TB, allowing users to store large amounts of data [9][10] Target Market - The T710 is designed for professional gamers and creators, while the X10 targets content creators, gamers, and general consumers who require fast and reliable storage solutions [4][10] - Both products are engineered to meet the increasing demands of AI applications, with the T710 enabling real-time local data processing on AI PCs [8][11] Availability - The Crucial X10 is currently available for purchase, while the T710 will be available starting in July 2025 [11]